{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:42:57Z","timestamp":1792651377988,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000053","name":"U.S. Department of Health & Human Services | NIH | National Eye Institute","doi-asserted-by":"publisher","award":["2P30EY002520"],"award-info":[{"award-number":["2P30EY002520"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Many patients of choroidal neovascularization (CNV) are unresponsive to the current anti-VEGF treatment. The mechanisms for anti-VEGF resistance are poorly understood. We explore the unique property of the apolipoprotein A-I (apoA-I) binding protein (AIBP) that enhances cholesterol efflux from endothelial cells and macrophages to thereby limit angiogenesis and inflammation to tackle anti-VEGF resistance in CNV. We show that laser-induced CNV in mice with increased age showed increased resistance to anti-VEGF treatment, which correlates with increased lipid accumulation in macrophages. The combination of AIBP\/apoA-I and anti-VEGF treatment overcomes anti-VEGF resistance and effectively suppresses CNV. Furthermore, macrophage depletion in old mice restores CNV sensitivity to anti-VEGF treatment and blunts the synergistic effect of combination therapy. These results suggest that cholesterol-laden macrophages play a critical role in inducing anti-VEGF resistance in CNV. Combination therapy by neutralizing VEGF and enhancing cholesterol removal from macrophages is a promising strategy to combat anti-VEGF resistance in CNV.<\/jats:p>","DOI":"10.1038\/s42003-020-1113-z","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:04:22Z","timestamp":1594893862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Combination of apolipoprotein-A-I\/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice"],"prefix":"10.1038","volume":"3","author":[{"given":"Lingping","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7010-4620","authenticated-orcid":false,"given":"Mackenzie","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nduka","family":"Enemchukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guogang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Handa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1653-5221","authenticated-orcid":false,"given":"Longhou","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"1113_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2, e106\u2013e116 (2014).","journal-title":"Lancet Global Health"},{"key":"1113_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0039-6257(88)90052-5","volume":"32","author":"NM Bressler","year":"1988","unstructured":"Bressler, N. M., Bressler, S. B. & Fine, S. L. Age-related macular degeneration. Surv. Ophthalmol. 32, 375\u2013413 (1988).","journal-title":"Surv. Ophthalmol."},{"key":"1113_CR3","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2147\/DDDT.S115121","volume":"10","author":"S Yang","year":"2016","unstructured":"Yang, S., Zhao, J. & Sun, X. Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review. Drug Des. Devel. Ther. 10, 1857\u20131867 (2016).","journal-title":"Drug Des. Devel. Ther."},{"key":"1113_CR4","first-page":"538","volume":"28","author":"C Ehlken","year":"2014","unstructured":"Ehlken, C. et al. Switch of anti-VEGF agents is an option for nonresponders in the treatment of AMD. Eye Lond. Engl. 28, 538\u2013545 (2014).","journal-title":"Eye Lond. Engl."},{"key":"1113_CR5","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.ophtha.2012.09.006","volume":"119","author":"JS Heier","year":"2012","unstructured":"Heier, J. S. et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119, 2537\u20132548 (2012).","journal-title":"Ophthalmology"},{"key":"1113_CR6","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.ophtha.2013.03.046","volume":"120","author":"S Rofagha","year":"2013","unstructured":"Rofagha, S. et al. Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology 120, 2292\u20132299 (2013).","journal-title":"Ophthalmology"},{"key":"1113_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/archopht.126.6.782","volume":"126","author":"O Tatar","year":"2008","unstructured":"Tatar, O. et al. Effect of bevacizumab on inflammation and proliferation in human choroidal neovascularization. Arch. Ophthalmol. 126, 782\u2013790 (2008).","journal-title":"Arch. Ophthalmol."},{"key":"1113_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.cmet.2013.03.009","volume":"17","author":"A Sene","year":"2013","unstructured":"Sene, A. et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 17, 549\u2013561 (2013).","journal-title":"Cell Metab."},{"key":"1113_CR9","doi-asserted-by":"publisher","first-page":"3586","DOI":"10.1167\/iovs.03-0038","volume":"44","author":"DG Espinosa-Heidmann","year":"2003","unstructured":"Espinosa-Heidmann, D. G. et al. Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3586\u20133592 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1113_CR10","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1167\/iovs.03-0097","volume":"44","author":"E Sakurai","year":"2003","unstructured":"Sakurai, E., Anand, A., Ambati, B. K., van Rooijen, N. & Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 44, 3578\u20133585 (2003).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1113_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1084\/jem.20022027","volume":"198","author":"S Ishida","year":"2003","unstructured":"Ishida, S. et al. VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization. J. Exp. Med. 198, 483\u2013489 (2003).","journal-title":"J. Exp. Med."},{"key":"1113_CR12","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/jcp.22708","volume":"227","author":"CN Nagineni","year":"2012","unstructured":"Nagineni, C. N., Kommineni, V. K., William, A., Detrick, B. & Hooks, J. J. Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration. J. Cell. Physiol. 227, 116\u2013126 (2012).","journal-title":"J. Cell. Physiol."},{"key":"1113_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature12166","volume":"498","author":"L Fang","year":"2013","unstructured":"Fang, L. et al. Control of angiogenesis by AIBP-mediated cholesterol efflux. Nature 498, 118\u2013122 (2013).","journal-title":"Nature"},{"key":"1113_CR14","doi-asserted-by":"publisher","unstructured":"Schneider, D. A. et al. AIBP protects against metabolic abnormalities and atherosclerosis. J. Lipid Res. https:\/\/doi.org\/10.1194\/jlr.M083618 (2018).","DOI":"10.1194\/jlr.M083618"},{"key":"1113_CR15","doi-asserted-by":"publisher","unstructured":"Zhang, M. et al. AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE-\/-mice. Atherosclerosis https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.010 (2018).","DOI":"10.1016\/j.atherosclerosis.2018.03.010"},{"key":"1113_CR16","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1016\/j.celrep.2018.04.110","volume":"23","author":"SA Woller","year":"2018","unstructured":"Woller, S. A. et al. Inhibition of neuroinflammation by AIBP: spinal effects upon facilitated pain states. Cell Rep. 23, 2667\u20132677 (2018).","journal-title":"Cell Rep."},{"key":"1113_CR17","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1167\/iovs.18-25215","volume":"59","author":"RD Makin","year":"2018","unstructured":"Makin, R. D. et al. RF\/6A chorioretinal cells do not display key endothelial phenotypes. Invest. Ophthalmol. Vis. Sci. 59, 5795\u20135802 (2018).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1113_CR18","doi-asserted-by":"crossref","unstructured":"Maekawa, M. Domain 4 (D4) of perfringolysin O to visualize cholesterol in cellular membranes-the update. Sensors 17, 504 (2017).","DOI":"10.3390\/s17030504"},{"key":"1113_CR19","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.4049\/jimmunol.1100253","volume":"187","author":"MB Fessler","year":"2011","unstructured":"Fessler, M. B. & Parks, J. S. Intracellular lipid flux and membrane microdomains as organizing principles in inflammatory cell signaling. J. Immunol. 187, 1529\u20131535 (2011).","journal-title":"J. Immunol."},{"key":"1113_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1432-1033.1989.tb15171.x","volume":"186","author":"Y Ohtani","year":"1989","unstructured":"Ohtani, Y., Irie, T., Uekama, K., Fukunaga, K. & Pitha, J. Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186, 17\u201322 (1989).","journal-title":"Eur. J. Biochem."},{"key":"1113_CR21","doi-asserted-by":"publisher","first-page":"e69552","DOI":"10.1371\/journal.pone.0069552","volume":"8","author":"Z Shao","year":"2013","unstructured":"Shao, Z. et al. Choroid sprouting assay: an ex vivo model of microvascular angiogenesis. PLoS ONE 8, e69552 (2013).","journal-title":"PLoS ONE"},{"key":"1113_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0305-0491(71)90234-3","volume":"40","author":"GL Mills","year":"1971","unstructured":"Mills, G. L. & Taylaur, C. E. The distribution and composition of serum lipoproteins in eighteen animals. Comp. Biochem. Physiol. Part B Comp. Biochem. 40, 489\u2013501 (1971).","journal-title":"Comp. Biochem. Physiol. Part B Comp. Biochem."},{"key":"1113_CR23","doi-asserted-by":"publisher","unstructured":"Mao, R. et al. AIBP limits angiogenesis through \u03b3-secretase-mediated upregulation of notch signaling. Circ. Res. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.309754 (2017).","DOI":"10.1161\/CIRCRESAHA.116.309754"},{"key":"1113_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jmoldx.2011.08.002","volume":"14","author":"F Wang","year":"2012","unstructured":"Wang, F. et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. JMD 14, 22\u201329 (2012).","journal-title":"J. Mol. Diagn. JMD"},{"key":"1113_CR25","doi-asserted-by":"publisher","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","volume":"10","author":"Y Gong","year":"2015","unstructured":"Gong, Y. et al. Optimization of an image-guided laser-induced choroidal neovascularization model in mice. PLoS ONE 10, e0132643 (2015).","journal-title":"PLoS ONE"},{"key":"1113_CR26","doi-asserted-by":"publisher","first-page":"546826","DOI":"10.1155\/2010\/546826","volume":"2010","author":"C Campa","year":"2010","unstructured":"Campa, C. et al. Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediat. Inflamm. 2010,\u00a0546826 (2010).","journal-title":"Mediat. Inflamm."},{"key":"1113_CR27","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1371\/journal.pmed.0030310","volume":"3","author":"RS Apte","year":"2006","unstructured":"Apte, R. S., Richter, J., Herndon, J. & Ferguson, T. A. Macrophages inhibit neovascularization in a murine model of age-related macular degeneration. PLoS Med. 3, e310 (2006).","journal-title":"PLoS Med."},{"key":"1113_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1136\/bjo.2009.165563","volume":"94","author":"S Cherepanoff","year":"2010","unstructured":"Cherepanoff, S., McMenamin, P., Gillies, M. C., Kettle, E. & Sarks, S. H. Bruch\u2019s membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br. J. Ophthalmol. 94, 918\u2013925 (2010).","journal-title":"Br. J. Ophthalmol."},{"key":"1113_CR29","first-page":"119","volume":"8","author":"HE Grossniklaus","year":"2002","unstructured":"Grossniklaus, H. E. et al. Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. Mol. Vis. 8, 119\u2013126 (2002).","journal-title":"Mol. Vis."},{"key":"1113_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2016.11.018","volume":"51","author":"S Hagbi-Levi","year":"2017","unstructured":"Hagbi-Levi, S. et al. Proangiogenic characteristics of activated macrophages from patients with age-related macular degeneration. Neurobiol. Aging 51, 71\u201382 (2017).","journal-title":"Neurobiol. Aging"},{"issue":"Pt 4","key":"1113_CR31","first-page":"613","volume":"4","author":"MC Killingsworth","year":"1990","unstructured":"Killingsworth, M. C., Sarks, J. P. & Sarks, S. H. Macrophages related to Bruch\u2019s membrane in age-related macular degeneration. Eye Lond. Engl. 4(Pt 4), 613\u2013621 (1990).","journal-title":"Eye Lond. Engl."},{"key":"1113_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S0161-6420(93)31657-X","volume":"100","author":"PF Lopez","year":"1993","unstructured":"Lopez, P. F., Lambert, H. M., Grossniklaus, H. E. & Sternberg, P. Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration. Ophthalmology 100, 415\u2013422 (1993).","journal-title":"Ophthalmology"},{"issue":"Pt 4","key":"1113_CR33","first-page":"515","volume":"11","author":"JP Sarks","year":"1997","unstructured":"Sarks, J. P., Sarks, S. H. & Killingsworth, M. C. Morphology of early choroidal neovascularisation in age-related macular degeneration: correlation with activity. Eye Lond. Engl. 11(Pt 4), 515\u2013522 (1997).","journal-title":"Eye Lond. Engl."},{"key":"1113_CR34","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1167\/iovs.06-0699","volume":"48","author":"M Kamei","year":"2007","unstructured":"Kamei, M. et al. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 48, 1801\u20131807 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1113_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1001\/archopht.118.5.625","volume":"118","author":"HE Grossniklaus","year":"2000","unstructured":"Grossniklaus, H. E. et al. Correlation of histologic 2-dimensional reconstruction and confocal scanning laser microscopic imaging of choroidal neovascularization in eyes with age-related maculopathy. Arch. Ophthalmol. 118, 625\u2013629 (2000).","journal-title":"Arch. Ophthalmol."},{"key":"1113_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000310075","volume":"200","author":"T Nishimura","year":"1990","unstructured":"Nishimura, T., Goodnight, R., Prendergast, R. A. & Ryan, S. J. Activated macrophages in experimental subretinal neovascularization. Ophthalmologica 200, 39\u201344 (1990).","journal-title":"Ophthalmologica"},{"key":"1113_CR37","first-page":"1891","volume":"40","author":"H Oh","year":"1999","unstructured":"Oh, H. et al. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci. 40, 1891\u20131898 (1999).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1113_CR38","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1001\/archopht.1986.01050210131040","volume":"104","author":"A Pollack","year":"1986","unstructured":"Pollack, A., Korte, G. E., Heriot, W. J. & Henkind, P. Ultrastructure of Bruch\u2019s membrane after krypton laser photocoagulation. II. Repair of Bruch\u2019s membrane and the role of macrophages. Arch. Ophthalmol. 104, 1377\u20131382 (1986).","journal-title":"Arch. Ophthalmol."},{"key":"1113_CR39","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1001\/archopht.120.3.338","volume":"120","author":"MG Krzystolik","year":"2002","unstructured":"Krzystolik, M. G. et al. Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch. Ophthalmol. 120, 338\u2013346 (2002).","journal-title":"Arch. Ophthalmol."},{"key":"1113_CR40","doi-asserted-by":"crossref","unstructured":"Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 83, 14 (2008).","DOI":"10.1002\/0471142735.im1401s83"},{"key":"1113_CR41","first-page":"1567","volume":"43","author":"DG Espinosa-Heidmann","year":"2002","unstructured":"Espinosa-Heidmann, D. G. et al. Age as an independent risk factor for severity of experimental choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 43, 1567\u20131573 (2002).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"1113_CR42","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.exer.2004.10.008","volume":"80","author":"DG Espinosa-Heidmann","year":"2005","unstructured":"Espinosa-Heidmann, D. G. et al. Gender and estrogen supplementation increases severity of experimental choroidal neovascularization. Exp. Eye Res. 80, 413\u2013423 (2005).","journal-title":"Exp. Eye Res."},{"key":"1113_CR43","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1016\/j.ajpath.2017.08.025","volume":"187","author":"S Kumar","year":"2017","unstructured":"Kumar, S. et al. Proteolytic degradation and inflammation play critical roles in polypoidal choroidal vasculopathy. Am. J. Pathol. 187, 2841\u20132857 (2017).","journal-title":"Am. J. Pathol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1113-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1113-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T02:35:39Z","timestamp":1670380539000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-020-1113-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["1113"],"URL":"https:\/\/doi.org\/10.1038\/s42003-020-1113-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"386"}}